Discover how hybrid vectors, lipopolyplexes, and virus-like particles overcome stability and targeting barriers for mRNA delivery in preclinical research. Introduction Messenger RNA (mRNA)-based therapeutics have transformed the landscape of vaccine development, geneRead More…
Explore advances in mRNA delivery, from lipid nanoparticles to polymer-based vectors, polyplexes and micelleplexes. Learn how tailored platforms support preclinical therapeutic development. Introduction Messenger RNA (mRNA) therapeutics have transitioned from a promisingRead More…
The scientific community is currently witnessing a renaissance in therapeutics, driven by the remarkable success of messenger RNA (mRNA). While the fundamental premise of mRNA—delivering a cellular “instruction manual” to produce therapeuticRead More…
The landscape of modern medicine is undergoing a seismic shift. If the last decade was defined by the rise of monoclonal antibodies, the current era belongs to programmable nucleic acids. mRNA technology,Read More…
In the rapidly evolving landscape of biopharmaceuticals, messenger RNA (mRNA) therapeutics have emerged as a transformative class of drugs. From prophylactic vaccines to protein replacement therapies and cancer immunotherapies, the potential ofRead More…
The biomedical landscape has shifted irrevocably. If the last decade was defined by the rise of biologics and monoclonal antibodies, the coming era belongs to messenger RNA (mRNA). From the rapid deploymentRead More…
The era of messenger RNA (mRNA) has arrived, transforming the landscape of vaccines and therapeutics. The rapid development and success of mRNA vaccines have been a landmark achievement in modern medicine. However,Read More…
Influenza A virus (IAV) is a persistent threat to global health, causing seasonal epidemics and occasional pandemics that result in significant morbidity and mortality. This negative-sense single-stranded RNA virus belongs to theRead More…
In recent years, mRNA technology has emerged as a transformative force in biomedical science, revolutionizing how we approach disease prevention and treatment. While its initial breakthrough with COVID-19 vaccines captured global attention,Read More…
Li Bowen of the University of Toronto and Daniel Anderson of the Massachusetts Institute of Technology published a research paper entitled “Accelerating ionizable lipid discovery for mRNA delivery using machine learning andRead More…